Numerous studies have reported that Rab31 participates in tumor initiation and progression across various cancers, including breast cancer, glioblastoma, and pancreatic cancer (Ioannou et al., 2015; Pan et al., 2016; Li H. et al., 2019). This evidence concerns the gene RAB31 and familial pancreatic carcinoma.